Related references
Note: Only part of the references are listed.Quitting Smoking At or Around Diagnosis Improves the Overall Survival of Lung Cancer Patients: A Systematic Review and Meta-Analysis
Saverio Caini et al.
JOURNAL OF THORACIC ONCOLOGY (2022)
Impact of Introducing Intensity Modulated Radiotherapy on Curative Intent Radiotherapy and Survival for Lung Cancer
Isabella Fornacon-Wood et al.
FRONTIERS IN ONCOLOGY (2022)
Real-World Treatment Patterns and Clinical Outcomes in Patients With Stage III NSCLC: Results of KINDLE, a Multicountry Observational Study
Abdul Rahman Jazieh et al.
JOURNAL OF THORACIC ONCOLOGY (2021)
Five-year survival outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLC: An update from the PACIFIC trial.
David R. Spigel et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Accelerated Hypofractionated Image-Guided vs Conventional Radiotherapy for Patients With Stage II/III Non-Small Cell Lung Cancer and Poor Performance Status A Randomized Clinical Trial
Puneeth Iyengar et al.
JAMA ONCOLOGY (2021)
Excess mortality and undertreatment in elderly lung cancer patients: treatment nihilism in the modern era?
Jonathan Pham et al.
ERJ OPEN RESEARCH (2021)
Survival and Toxicity of Hypofractionated Intensity Modulated Radiation Therapy in 4 Gy Fractions for Unresectable Stage III Non-Small Cell Lung Cancer
Cheng Kong et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)
Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer
Yi-Long Wu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Retrospective cohort study of unresectable stage III non-small-cell lung cancer in Canada
S. J. Seung et al.
CURRENT ONCOLOGY (2020)
Frailty assessment predicts toxicity during first cycle chemotherapy for advanced lung cancer regardless of chronologic age
Jimmy Ruiz et al.
JOURNAL OF GERIATRIC ONCOLOGY (2019)
Stage III Non-small Cell Lung Cancer Management in England
J. B. Adizie et al.
CLINICAL ONCOLOGY (2019)
The Addition of Chemotherapy to Radiation Therapy Improves Survival in Elderly Patients with Stage III Non-Small Cell Lung Cancer
Eric D. Miller et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Patterns of treatment and survival among older patients with stage III non-small cell lung cancer
Elisabeth J. M. Driessen et al.
LUNG CANCER (2018)
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
S. J. Antonia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial
Stephen G. Chun et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Increasing Rates of No Treatment in Advanced-Stage Non-Small Cell Lung Cancer Patients: A Propensity-Matched Analysis
Elizabeth A. David et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer
S. J. Antonia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
P. E. Postmus et al.
ANNALS OF ONCOLOGY (2017)
The Eighth Edition Lung Cancer Stage Classification
Frank C. Detterbeck et al.
CHEST (2017)
Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancer
D. A. Fennell et al.
CANCER TREATMENT REVIEWS (2016)
Hypofractionated Intensity-Modulated Radiotherapy for Patients With Non-Small-Cell Lung Cancer
Erqi L. Pollom et al.
CLINICAL LUNG CANCER (2016)
Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC-GECP 08-02 Study
Romain Corre et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Stage III Non-Small Cell Lung Cancer in the elderly: Patient characteristics predictive for tolerance and survival of chemoradiation in daily clinical practice
Elisabeth J. M. Driessen et al.
RADIOTHERAPY AND ONCOLOGY (2016)
Use of Simultaneous Radiation Boost Achieves High Control Rates in Patients With Non-Small-Cell Lung Cancer Who Are Not Candidates for Surgery or Conventional Chemoradiation
Cameron W. Swanick et al.
CLINICAL LUNG CANCER (2015)
Precision Hypofractionated Radiation Therapy in Poor Performing Patients With Non-Small Cell Lung Cancer: Phase 1 Dose Escalation Trial
Kenneth D. Westover et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Distance as a Barrier to Cancer Diagnosis and Treatment: Review of the Literature
Massimo Ambroggi et al.
ONCOLOGIST (2015)
Lung cancer treatment rates and the role of the lung cancer nurse specialist: a qualitative study
Angela Mary Tod et al.
BMJ OPEN (2015)
Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer
Brenda K. Edwards et al.
CANCER (2014)
The Victorian Lung Cancer Registry Pilot: Improving the Quality of Lung Cancer Care Through the Use of a Disease Quality Registry
Rob G. Stirling et al.
LUNG (2014)
Lung cancer in Victoria: are we making progress?
Paul L. R. Mitchell et al.
MEDICAL JOURNAL OF AUSTRALIA (2013)
Accelerated hypo-fractionated radiotherapy for non small cell lung cancer: Results from 4 UK centres
Omar S. Din et al.
RADIOTHERAPY AND ONCOLOGY (2013)
Impact of Age and Comorbidity on Non-Small-Cell Lung Cancer Treatment in Older Veterans
Sunny Wang et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Accelerated hypofractionated radiation therapy compared to conventionally fractionated radiation therapy for the treatment of inoperable non-small cell lung cancer
Arya Amini et al.
RADIATION ONCOLOGY (2012)
Treatment of the Elderly When Cure is the Goal The Influence of Age on Treatment Selection and Efficacy for Stage III Non-small Cell Lung Cancer
Linda E. Coate et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Population-Based Estimates of Survival Benefit Associated with Combined Modality Therapy in Elderly Patients with Locally Advanced Non-small Cell Lung Cancer
Amy J. Davidoff et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Distance to the closest radiotherapy facility and survival after a diagnosis of rectal cancer in Queensland
Peter D. Baade et al.
MEDICAL JOURNAL OF AUSTRALIA (2011)
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non-Small-Cell Lung Cancer
Anne Auperin et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: a prospective, population-based study
D. De Ruysscher et al.
ANNALS OF ONCOLOGY (2009)
Lung Adjuvant Cisplatin Evaluation: A pooled analysis by the LACE collaborative group
Jean-Pierre Pignon et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Patients' preference for radiotherapy fractionation schedule in the palliation of symptomatic unresectable lung cancer
J. I. Tang et al.
JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY (2008)
Gaps in optimal care for lung cancer
Shalini K. Vinod et al.
JOURNAL OF THORACIC ONCOLOGY (2008)
Comparison of patterns of care in lung cancer in three area health services in New South Wales, Australia
SK Vinod et al.
INTERNAL MEDICINE JOURNAL (2004)
Lung cancer patterns of care in south western Sydney, Australia
SK Vinod et al.
THORAX (2003)
Reported management of lung cancer in Victoria in 1993: comparison with best practice
GE Richardson et al.
MEDICAL JOURNAL OF AUSTRALIA (2000)